Targeted Therapies and their Impact on Melanoma
Steven O’Day, MD
Video Categories: Targeted Therapies
Dixie-Lee Esseltine, MD provides a brief overview of the dosing schedule and indications of ixazomib. She also reviews the phase 3 clinical trials of ixazomib that are currently ongoing.
Linda Bosserman provides an overview of the nuances of personalized medicine as it relates to cost, value and access